Dr. Tanya Gottlieb has a wealth of experience in the fields of biotechnology, diagnostics, and healthcare. Today, she serves as Vice President of Scientific Affairs at MeMed, a company pioneering host response technologies. Tanya is responsible for driving international collaborations aimed at improving management of patients with acute infection, promoting responsible use of antibiotics through innovative tools that support decision-making. She has coordinated governmental partnerships that establish MeMed’s lead technology for differentiating between bacterial and viral infection as a flagship innovation supporting appropriate antibiotic use. Dr. Gottlieb conducted her postdoctoral research at the Weizmann Institute of Science, Israel and the Fred Hutchinson Cancer Research Center in Seattle, WA, USA. She holds a BA in Natural Sciences and a PhD from Cambridge University in the UK and an MBA from the Technion in Israel.
Tanya Gottlieb
